Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REPAGLINIDE vs REVEFENACIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REPAGLINIDE vs REVEFENACIN: Safety Overview

Metric REPAGLINIDE REVEFENACIN
Total FAERS Reports 2,544 280
Deaths Reported 169 11
Death Rate 6.6% 3.9%
Hospitalizations 1,517 23
Average Patient Age 71.9 yrs 72.4 yrs
% Female Patients 45.5% 59.1%
FDA Approval Date Apr 24, 2015 Nov 9, 2018
Manufacturer Rising Pharma Holdings, Inc. Viatris Specialty LLC
Route ORAL RESPIRATORY (INHALATION)
Marketing Status Discontinued Prescription